Portal de investigación
The SafeBoosC phase II clinical trial: an analysis of the interventions related with the oximeter readings
Autores de IIS La Fe
Participantes ajenos a IIS La Fe
- Riera J
- Hyttel-Sorensen S
- Bravo MC
- Cabañas F
- López-Ortego P
- Sanchez L
- Ybarra M
- Dempsey E
- Greisen G
- Austin T
- Claris O
- Fumagalli M
- Gluud C
- Lemmers P
- Pichler G
- Plomgaard AM
- van Bel F
- Wolf M
Grupos
Abstract
Background The SafeBoosC phase II randomised clinical trial recently demonstrated the benefits of a combination of cerebral regional tissue oxygen saturation (rStO(2)) by near-infrared spectroscopy (NIRS) and a treatment guideline to reduce the oxygen imbalance in extremely preterm infants. Aims To analyse rStO(2)-alarm-related clinical decisions and their heterogeneity in the NIRS experimental group (NIRS monitoring visible) and their impact on rStO(2) and SpO(2). Methods Continuous data from NIRS devices and the alarms (area under the curve of the rStO(2) out of range had accumulated 0.2% h during 10 min), clinical data at discrete time points and interventions prompted by the alarms were recorded. Results Sixty-seven infants had data that fulfilled the requirements for this analysis. 1107 alarm episodes were analysed. The alarm triggered a treatment guideline intervention in 25% of the cases; the type of intervention chosen varied among clinical sites. More than 55% of alarms were not followed by an intervention ('No action'); additionally, in 5% of alarms the rStO(2) value apparently was considered non-reliable and the sensor was repositioned. The percentage of unresolved alarms at 30 min after 'No action' almost doubled the treatment guideline intervention (p<0.001). Changes in peripheral oxygen saturation (SpO(2)), were observed only after treatment guideline interventions. Conclusions This study shows that 25% of rStO(2) alarms were followed by a clinical intervention determined by the treatment guideline. However, the rStO(2) and SpO(2) returned to normal ranges after the intervention, supporting the notion that decisions taken by the clinicians were appropriate.
Datos de la publicación
- ISSN/ISSNe:
- 1359-2998, 1468-2052
- Tipo:
- Article
- Páginas:
- 333-338
- Factor de Impacto:
- 1,655 SCImago ℠
- Cuartil:
- Q1 SCImago ℠
ARCHIVES OF DISEASE IN CHILDHOOD-FETAL AND NEONATAL EDITION BMJ PUBLISHING GROUP
Citas Recibidas en Web of Science: 14
Documentos
- No hay documentos
Filiaciones
Keywords
- Intensive Care, Monitoring, Neonatology
Proyectos asociados
ESTUDIO DE LA ENFERMEDAD METASTASICA EN EL TEJIDO OVARICO CRIOPRESERVADO DE MUJERES CON CANCER DE MAMA
Investigador Principal: ANTONIO PELLICER MARTÍNEZ
PI08/90483 . INSTITUTO DE SALUD CARLOS III . 2009
CONTRATO POSTDOCTORAL DE INVESTIGACION SARA BORRELL
CD11/00292 . INSTITUTO DE SALUD CARLOS III; FUNDACIÓN PARA LA INVESTIGACIÓN DEL HOSPITAL UNIVERSITARIO LA FE DE LA COMUNIDAD VALENCIANA . 2012
CONTRATO POSTDOCTORAL DE INVESTIGACION SARA BORELL
CD12/00568 . INSTITUTO DE SALUD CARLOS III; FUNDACIÓN PARA LA INVESTIGACIÓN DEL HOSPITAL UNIVERSITARIO LA FE DE LA COMUNIDAD VALENCIANA . 2013
CONTRATO POST FSE (RIO HORTEGA)
CM13/00191 . INSTITUTO DE SALUD CARLOS III; FUNDACIÓN PARA LA INVESTIGACIÓN DEL HOSPITAL UNIVERSITARIO LA FE DE LA COMUNIDAD VALENCIANA . 2014
CONTRATO POSTDOCTORAL DE INVESTIGACION SARA BORRELL
Investigador Principal: ANTONIO PELLICER MARTÍNEZ
CD15/00058 . INSTITUTO DE SALUD CARLOS III; FUNDACIÓN PARA LA INVESTIGACIÓN DEL HOSPITAL UNIVERSITARIO LA FE DE LA COMUNIDAD VALENCIANA . 2016
TRAMIENTO COMBINADO DE VITAMINA D CON AGNRH SOBRE EL CRECIMIENTO DE LOS MIOMAS UTERINOS
Investigador Principal: ANTONIO PELLICER MARTÍNEZ
PI15/00312 . INSTITUTO DE SALUD CARLOS III . 2016
Cita
Riera J,Hyttel S,Bravo MC,Cabañas F,López P,Sanchez L,Ybarra M,Dempsey E,Greisen G,Austin T,Claris O,Fumagalli M,Gluud C,Lemmers P,Pichler G,Plomgaard AM,van F,Wolf M,Pellicer A. The SafeBoosC phase II clinical trial: an analysis of the interventions related with the oximeter readings. Arch Dis Child Fetal Neonatal Ed. 2016. 101. (4):p. 333-338. IF:3,786. (1).